Terbutaline - Juniper/Ardana

Drug Profile

Terbutaline - Juniper/Ardana

Alternative Names: Chronodyne

Latest Information Update: 21 Apr 2015

Price : $50

At a glance

  • Originator Columbia Laboratories
  • Developer Ardana plc
  • Class Antiasthmatics; Antibronchitics; Bronchodilators; Ethanolamines; Small molecules; Tocolytics
  • Mechanism of Action Beta 2 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Suspended Female infertility

Most Recent Events

  • 01 Apr 2015 Columbia Laboratories is now called Juniper Pharmaceuticals
  • 03 Dec 2007 Suspended - Phase-II for Female infertility in Germany (Vaginal)
  • 03 Dec 2007 Suspended - Phase-II for Female infertility in USA (Vaginal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top